Suppr超能文献

鼻内新斯的明对重症肌无力的急性治疗:临床和肌电图评估

Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.

作者信息

Ricciardi R, Rossi B, Nicora M, Sghirlanzoni A, Muratorio A

机构信息

Institute of Neurological Clinic, University of Pisa, Italy.

出版信息

J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1061-2. doi: 10.1136/jnnp.54.12.1061.

Abstract

The effectiveness of intranasal neostigmine (9.3-13.8 mg) was tested in 20 subjects with myasthenia gravis, classified as Osserman grades 2A and 2B. In all cases the drug produced significant clinical and electromyographic improvement. No side effects were reported during the treatment.

摘要

对20例诊断为Osserman 2A和2B级的重症肌无力患者,测试了鼻内给予新斯的明(9.3 - 13.8毫克)的有效性。在所有病例中,该药物均产生了显著的临床和肌电图改善。治疗期间未报告副作用。

相似文献

4
Acetylcholinesterase inhibitor treatment for myasthenia gravis.重症肌无力的乙酰胆碱酯酶抑制剂治疗
Cochrane Database Syst Rev. 2014 Oct 13;2014(10):CD006986. doi: 10.1002/14651858.CD006986.pub3.

引用本文的文献

2
Endoscopic thymectomy: a neurologist's perspective.内镜下胸腺切除术:神经科医生的观点。
Ann Cardiothorac Surg. 2016 Jan;5(1):38-44. doi: 10.3978/j.issn.2225-319X.2015.12.02.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验